期刊文献+

有限采样策略估算肾移植受者霉酚酸钠药-时曲线下面积方法的建立 被引量:7

Use of limited sampling strategy for estimating area under concentration-versus-time curve of mycophenolate sodium in renal allograft recipients
原文传递
导出
摘要 目的建立有限采样策略估算。肾移植受者霉酚酸钠药.时曲线下面积(AUC)的公式。方法2010--2013年南京军区福州总医院接受霉酚酸钠肠溶片(EC-MPS)联合钙调磷酸蛋白酶抑制剂(CNI)及泼尼松三联免疫抑制治疗的35例肾移植受者,血霉酚酸浓度采用均相酶免疫分析(EMIT)法测定,测定时间点为服药前及服药后0.5、1.0、1.5、2.0、3.0、4.0、6.0、8.0、12.0h。采用WINNOLIN软件计算霉酚酸的药代动力学参数。多元逐步回归分析法得出适合中国人群服用不同CNI药物时的简化霉酚酸药-时AUC计算公式。结果35例受者霉酚酸的AUC0-12b为14~67mg·h/L,平均(37±14)mg·h/L;不同肾移植受者之间药代动力学参数个体差异大,霉酚酸的谷浓度(C0)与霉酚酸的AUC0-12b相关性差(r2=0.090)。服用他克莫司的受者采用4个时间点取样的霉酚酸浓度(C4、C6、C8、C12)得出霉酚酸的AUC简化计算公式为AUC=5.678+1.718×C4+2.853×C6+1.812XC8+3.413×C12;该公式的霉酚酸AUC预测值与AUC0-12h实测值相关性较好(r2=0.890,P〈0.05),绝对预测误差中位数为3.45%(0.41%~24.71%),误差超过15%的比例为11.1%(2/18)。服用环孢素A的患者采用4个时间点取样的霉酚酸浓度(C3、C4、C6、C7)得出霉酚酸AUC简化计算公式为AUC=7.072+1.525XC3+1.558×C4+1.573XC6+2.285×CE;该公式的霉酚酸AUC预测值与AUC0-12h实测值相关性好(r2=0.952,P〈0.05),绝对预测误差中位数为6.50%(0.02%-12.91%),误差超过15%的比例为0。上述两个公式经Bland-Altman分析,与霉酚酸AUC0-12h一致性良好。结论本研究拟合的4点霉酚酸AUC简化计算公式能较好地反映霉酚酸药.时AUC,适用于肾移植受者服用EC—MPS的治疗药物监测。 Objective To establish a formula for estimating area under the concentration-versus- time curve (AUC) of mycophenolate sodium in Chinese renal allograft recipients with a limited sampling model. Methods A total of 35 renal allograft recipients were recruited from 2010 to 2013 to receive enteric- coated mycophenolate sodium ( EC-MPS), calcineurin (CNI) and prednisone as immunosuppressive triple therapy. The serum concentration of mycophenolic acid (MPA) was assayed by enzyme multiplied immunoassay technique (EMIT) at pre-dose ( Co ), 0. 5 ( C0.5 ), 1.0 ( C1 ), 1.5 ( C1.5 ), 2. 0 ( C2 ), 3.0 (C3 ), 4. 0 ( C4 ), 6.0 ( C6 ), 8.0 ( Cs ) and 12.0 ( C,2 ) h post-dose respectively. Pharmacokinetic parameters of MPA ( Co, CI2, Cm~, T AUC0-12 h) were calculated by software WINNOLIN. Simplified formulae for estimation of MPA-AUC in tacrolimus ( Tac ) group or cyclosporin A ( CsA ) group were established by multiple stepwise regression analysis. Results There were variable MPA AUC0_12 h levels between 14 and 67 mg h/L (mean: 37 + 14). The MPA trough level (Co) had no correlations with MPA AUC0-12h(r2 =0. 090). The simplified MPA AUC formula for Tac group was AUC = 5. 678 + 1. 718 x C4 +2. 853 x C6 + 1. 812 x Cs + 3. 413 x CIz with four sampling points ( C4, C6 , C8 , C12 ). Estimated AUC with the formula had eorrelations with AUC0_lz h ( r2 = 0. 890 ). The mean absolute prediet error (APE) was 3.45% (0. 41% -24. 71% ) and the proportion of APE above 15% stood at 11.1% (2/18). In CsA group, the simplified MPA AUC formula was AUC = 7. 072 + 1. 525 C3 + 1. 558 x C4 + 1. 573 x C6 + 2. 285 x C8. The correlation was r2 =0. 952, mean APE was 6. 50% (0.02% - 12. 91% ) and proportion of APE above 15% stood at 0. The above formulae were observed to have agreement with AUC0-12h by Bland-Ahman analysis. Conelusion The simplified MPA AUC formulae with 4-point sampling provide an effective approach for estimating full MPA AUC0-12h in Chinese renal recipients on EC-MPS plus tacrolimus or cyclosporin A.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第48期3841-3846,共6页 National Medical Journal of China
基金 卫生部国际交流与合作中心合作项目(IHECC08-201216)
关键词 肾移植 霉酚酸 药代动力学 药物监测 有限采样法 Kidney transplantation Mycophenolic acid Pharmacokinetics Drug monitoring Limited sampling strategy
  • 相关文献

参考文献16

  • 1Hughes SE,Gruber SA. New immunosuppressive drugs in organ transplantation[J].{H}Journal of Clinical Pharmacology,1996.1081-1092.
  • 2Sollinger HW,Sundberg AK,Leverson G. Mycophenolate mofetil versus enteric-coated mycophenolate sodium:a large,single-center comparison of dose adjustments and outcomes in kidney transplant recipients[J].{H}TRANSPLANTATION,2010.446-451.
  • 3Barraclough KA,Isbel NM,Staatz CE. Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE,FDCC,and Opticept trials[J].{H}TRANSPLANTATION,2010.44-51.
  • 4Le Meur Y,Btichler M,Thierry A. Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation[J].{H}AMERICAN JOURNAL OF TRANSPLANTATION,2007.2496-2503.
  • 5Van Gelder T,Silva HT,de Fijter JW. Comparing mycophenolate mofetil regimens for de novo renal transplant recipient:the fixed-dose concentration-controlled trial[J].{H}TRANSPLANTATION,2008.1043-1051.
  • 6Gaston RS,Kaplan B,Shah T. Fixed-or controlled-dose mycophenolate mofetil with standard-or reduced-dose calcineurin inhibitors:the Opticept trial[J].{H}AMERICAN JOURNAL OF TRANSPLANTATION,2009.1607-1619.
  • 7叶丽卡,谢志红,王若伦,方佳丽,唐波.有限采样法估算霉酚酸药-时曲线下面积[J].中国药学杂志,2009,44(8):611-614. 被引量:12
  • 8周佩军,徐达,王祥慧,余自成,赵菊平.肾移植受者霉酚酸治疗药物监测[J].上海交通大学学报(医学版),2006,26(6):680-684. 被引量:11
  • 9刘岩峰,李军,黄珈雯,傅茜,刘龙山,陈锷,黄民,王长希.肾移植术后配伍他克莫司时血霉酚酸浓度测定的有限检样法研究[J].中华器官移植杂志,2012,33(2):101-104. 被引量:16
  • 10Capone D,Tarantino G,Kadilli I. Evaluation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine[J].Nephrol Transplant,2011.3019-3025.

二级参考文献47

  • 1石茹,文爱东,赵磊,林琳,王萌,吴寅.HPLC法测定肾脏移植患者血浆中霉酚酸浓度及其药代动力学[J].第四军医大学学报,2004,25(15):1416-1418. 被引量:13
  • 2周佩军,徐达,王祥慧,余自成,赵菊平.肾移植受者霉酚酸治疗药物监测[J].上海交通大学学报(医学版),2006,26(6):680-684. 被引量:11
  • 3丁俊杰,焦正,李中东,施孝金,钟明康.有限采样法估算口服托烷司琼药时曲线下面积模型的建立和验证[J].复旦学报(医学版),2006,33(6):770-775. 被引量:4
  • 4陈卉.Bland-Altman分析在临床测量方法一致性评价中的应用[J].中国卫生统计,2007,24(3):308-309. 被引量:217
  • 5STAATZ C E, TETT S E. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients[J]. Clin Pharmacokinet, 2007, 46(1): 13-58.
  • 6WESTLEY I S, BROGAN L R, MORRIS R G, et al. Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect ofcyclosporine[J]. Drug Metab Dispos, 2006, 34(2): 261-266.
  • 7GUIDO F. Abbreviated mycophenolic acid AUC from CO, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy[J]. Transpl Int, 2004, 17 (3) : 120-125.
  • 8FATELA C D, HINOJOSA P R, PERALVO R, et al. Pharmacokinetic evaluation of mycophenolic acid profiles during the period immediately following an orthotopic liver transplant[J]. Transplant Proc, 2006, 38(8): 2482-2485.
  • 9JIAO Z, ZHONG J Y, ZHANG M, et al. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limitedsamplingstrategies[J].Eur J Clin Pharmacol, 2007, 63(2): 27-37.
  • 10TING L S, PARTOVI N, LEVY R D, et al. Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients[J]. Pharmacotherapy, 2006, 26(9): 1232-1240.

共引文献162

同被引文献45

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部